Fibromyalgia
📧 Sign up to get email alerts when something new happens for Fibromyalgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-09FDA Approved: DULOXETINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for duloxetine hydrochloride as a generic product from Alembic Pharmaceuticals Limited.
-
FDA approval · 2026-02-24FDA Approved: PREGABALIN — Original Application (FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED)
FDA approved the original Abbreviated New Drug Application for pregabalin from Fourrts (India) Laboratories Private Limited, granting a gene…
-
FDA approval · 2026-02-02FDA Approved: PREGABALIN — Supplemental Application (Tris Pharma Inc)
FDA approves Tris Pharma Inc's supplemental application for pregabalin.
-
FDA approval · 2025-10-01FDA Approved: PREGABALIN — Supplemental Application (Creekwood Pharmaceuticals LLC)
The FDA approved a supplemental application for pregabalin from Creekwood Pharmaceuticals LLC under ANDA213423.
-
FDA approval · 2025-09-17FDA Approved: PREGABALIN — Supplemental Application (MARKSANS PHARMA LIMITED)
The FDA approved a supplemental application for pregabalin from Marksans Pharma Limited, resulting in approval of a generic pregabalin produ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-09-10FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Savella (milnacipran hydrochloride) from Allergan, Inc.
-
FDA approval · 2025-08-21FDA Approved: PREGABALIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental ANDA for pregabalin, authorizing the marketing of a generic pregabalin product.
-
FDA approval · 2025-08-21FDA Approved: PREGABALIN — Supplemental Application (ScieGen Pharmaceuticals, Inc)
FDA approved a supplemental application for pregabalin from ScieGen Pharmaceuticals, Inc., confirming approval of the generic product under …
-
FDA approval · 2025-08-18FDA Approved: PREGABALIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Pregabalin submitted by Rising Pharma Holdings, Inc. under the approved ANDA.
-
FDA approval · 2025-08-15FDA Approved: PREGABALIN — Supplemental Application (Indoco Remedies Limited)
FDA approved a supplemental application for pregabalin from Indoco Remedies Limited, resulting in approval of a generic pregabalin product.
-
FDA approval · 2025-07-21FDA Approved: PREGABALIN — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application for pregabalin. The approval enables the marketing of a generic pregabalin pr…
-
FDA approval · 2025-07-21FDA Approved: PREGABLIN — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for pregabalin from Macleods Pharmaceuticals Limited, authorizing a generic version of the drug. Thi…
-
FDA approval · 2025-07-07FDA Approved: PREGABALIN — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approves a supplemental application for Pregabalin from Torrent Pharmaceuticals Limited, enabling the generic drug to be marketed.
-
FDA approval · 2025-07-07FDA Approved: PREGABALIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for pregabalin filed by Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2025-07-01FDA Approved: PREGABALIN CAPSULES, CV — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Pregabalin Capsules, CV from Cipla USA Inc., under ANDA to market this generic pregabalin capsul…
-
FDA approval · 2025-04-30FDA Approved: PREGABALIN — Supplemental Application (Cipla USA, Inc.)
The FDA approved Cipla's supplemental application to market a generic pregabalin product, enabling a generic version of the drug for its app…
-
FDA approval · 2025-03-28FDA Approved: DULOXETINE DELAYED-RELEASE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved Breckenridge Pharmaceutical's supplemental ANDA for a duloxetine hydrochloride delayed-release product, making a generic du…
-
FDA approval · 2025-02-21FDA Approved: PREGABALIN — Original Application (Torrent Pharmaceuticals Limited)
FDA approved a generic pregabalin product from Torrent Pharmaceuticals Limited (ANDA 206942) to be used for the same indications as the refe…
-
CLINICAL_TRIALS approval · 2025-01-10Clinical Trial Update: Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
Clinical trial update indicates that duloxetine, sponsored by Eli Lilly, has been approved for marketing in relation to a compassionate-use …
-
FDA approval · 2024-12-23FDA Approved: PREGABALIN — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for pregabalin filed by Chartwell RX, LLC (ANDA212865).
-
FDA approval · 2024-12-19FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' supplemental application for pregabalin (generic pregabalin).
-
FDA approval · 2024-12-12FDA Approved: PREGABALIN — Supplemental Application (Advagen Pharma Ltd.)
FDA approved the supplemental application for pregabalin from Advagen Pharma Ltd., authorizing the generic product under an ANDA.
-
FDA approval · 2024-10-03FDA Approved: MILNACIPRAN HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approves Camber Pharmaceuticals' original application for milnacipran hydrochloride, a generic product.
-
FDA approval · 2024-08-28FDA Approved: PREGABALIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for pregabalin.
-
FDA approval · 2024-08-23FDA Approved: PREGABALIN — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for pregabalin from Solco Healthcare US, LLC, granting approval for changes related to the generic p…